Search details
1.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Cancer
; 2024 Jan 18.
Article
in English
| MEDLINE | ID: mdl-38236702
2.
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.
J Clin Oncol
; 39(23): 2539-2551, 2021 08 10.
Article
in English
| MEDLINE | ID: mdl-34092112
3.
Reply to T. Shimoi et al and Y. Shimanuki et al.
J Clin Oncol
; 39(31): 3522-3524, 2021 11 01.
Article
in English
| MEDLINE | ID: mdl-34554848
4.
Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report.
Oncology (Williston Park)
; 17(9 Suppl 8): 23-6, 2003 Sep.
Article
in English
| MEDLINE | ID: mdl-14569844
Results
1 -
4
de 4
1
Next >
>>